ACADIA Pharmaceuticals, Inc.

Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)

Market Report, "ACADIA Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review", published

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Comple

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock

Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIA

Acadia Pharmaceuticals Inc. - Product Pipeline Review - 2013 - New Market Study Published

Critical Alerts For Chevron, MGM Mirage, Charter Communications, Quanta Services, and Acadia Released By InvestorsObserver

Acadia Pharmaceuticals Expects $100M in Public Offering

ACADIA Pharma Floats New Stock Issue

Acadia Pharmaceuticals, (ACAD) Prices 8M Shares Offering at $12.50/Sh